Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

Rhea-AI Summary

Liquidia (NASDAQ:LQDA) announced that executives Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief Business Officer, will provide a business update in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026 at 8:45 a.m. ET. Access to the live webcast and an archived replay for at least 30 days will be available via the Investors section of Liquidia’s website.

Market Context

Liquidia's prior earnings event drew a -10.61% 24-hour reaction despite strong reported results; thi...

Analysis

Liquidia's prior earnings event drew a -10.61% 24-hour reaction despite strong reported results; this conference update adds no quantified operating outcome, while Net Selling and moderate short positioning remain relevant risks to monitor.

Key Figures

Conference edition: 21st annual Event date: September 8, 2026 Event time: 8:45 a.m. ET +1 more

4 metrics

Conference edition 21st annual Wells Fargo Annual Healthcare Conference

Event date September 8, 2026 Wells Fargo Annual Healthcare Conference

Event time 8:45 a.m. ET Fireside chat

Replay duration at least 30 days Webcast archive

Historical Context

5 past events · Latest: Aug 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 12	earnings report	Positive	-10.6%	Strong second-quarter revenue, profitability, cash growth, and YUTREPIA prescription expansion
Jul 29	earnings date notice	Neutral	+0.0%	Scheduled second-quarter results release and webcast for August 12, 2026
Jun 11	conference poster presentation	Neutral	+9.8%	Four posters covering YUTREPIA clinical, patient-reported, and caregiver-related topics
Jun 08	index inclusion	Positive	+3.3%	Inclusion in the S&P SmallCap 600 Index effective before market open
May 27	conference presentation	Neutral	+3.2%	Fireside chat scheduled at the Jefferies Global Healthcare Conference

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Liquidia's recent news reactions were mixed, including a -10.61% 24-hour reaction after a positive second-quarter earnings report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief Business Officer, will provide an update on the company’s business in a fireside chat at the Wells Fargo 21^st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026 at 8:45 a.m. ET.

Access to this event will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A replay of the webcast will be archived on the Company's website for at least 30 days.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases through precise, innovative therapies and applications of its proprietary PRINT^® technology. PRINT enabled the development of YUTREPIA^® (treprostinil) inhalation powder for the treatment of PAH and PH-ILD. The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com.

Contact Information

Investors:
Jason Adair
Chief Business Officer
919.328.4350
Jason.adair@liquidia.com

Media:
media@liquidia.com

FAQ

When will Liquidia (NASDAQ:LQDA) present at the Wells Fargo 21st Annual Healthcare Conference in 2026?

Liquidia will present on Tuesday, September 8, 2026 at 8:45 a.m. ET. According to Liquidia, executives will provide a business update during a fireside chat at the Wells Fargo 21st Annual Healthcare Conference in Boston.

Which Liquidia executives will speak at the Wells Fargo Healthcare Conference 2026 for LQDA investors?

According to Liquidia, Michael Kaseta and Jason Adair will speak at the conference. Kaseta serves as Chief Operating Officer and Chief Financial Officer, while Adair is Chief Business Officer, and together they will provide a company business update.

How can investors access Liquidia’s Wells Fargo Healthcare Conference 2026 webcast for LQDA?

Investors can access the webcast via the Investors page on Liquidia’s website. According to Liquidia, the specific link is provided under Events and Presentations at https://liquidia.com/investors/events-and-presentations on the day of the event.

Will there be a replay of Liquidia’s September 8, 2026 Wells Fargo conference presentation?

Yes, a replay will be available on Liquidia’s website after the event. According to Liquidia, the webcast replay will be archived on the company’s site for at least 30 days for investors to review.

What type of update will Liquidia provide at the Wells Fargo 21st Annual Healthcare Conference 2026?

Liquidia will provide a business update in a fireside chat format. According to Liquidia, executives Michael Kaseta and Jason Adair will discuss the company’s business during the session at the Wells Fargo healthcare conference.